SCHEMBL25914718

SCHEMBL25914718

CNc1ncc(-c2ccc3cc(Oc4ccnc(NCc5ccc(OC)cc5)c4F)ccc3n2)c(=O)n1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 4/20 0.38
▸ MET P08581 4/20 0.38
▸ LCK P06239 2/20 0.38
▸ MST1R Q04912 2/20 0.38
▸ AURKA O14965 1/20 0.38
▸ RPS6KA5 O75582 1/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ HGF P14210 1/20 0.38
▸ RPS6KB1 P23443 1/20 0.38
▸ MAPK9 P45984 1/20 0.38
▸ TEK Q02763 1/20 0.38
▸ BTK Q06187 1/20 0.38
▸ CSF1R P07333 2/20 0.37
▸ PDGFRB P09619 2/20 0.37
▸ KIT P10721 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ PDGFRA P16234 1/20 0.37
▸ FLT3 P36888 1/20 0.37
▸ PTK6 Q13882 1/20 0.37
▸ CYP3A4 P08684 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25914917 0.90 CYP3A4 (0.35) KDRMETLCKMST1RAURKA
SCHEMBL25914717 0.85 CSF1R (0.42) KDRMETLCKMST1RAURKA
SCHEMBL25915040 0.84 KDR (0.37) KDRMETLCKMST1RAURKA
SCHEMBL25910908 0.83 CSF1R (0.41) KDRMETLCKMST1RAURKA
SCHEMBL25914759 0.83 LCK (0.44) KDRMETLCKMST1RAURKA
SCHEMBL25914712 0.81 CYP3A4 (0.45) CYP3A4MAPTTP53
SCHEMBL25914529 0.80 GAA (0.41) KDRLCKCSF1RPDGFRBKIT
SCHEMBL25914570 0.78 CSF1R (0.42) KDRMETLCKMST1RAURKA
SCHEMBL25910688 0.78 CSF1R (0.40) KDRMETLCKMST1RAURKA
SCHEMBL25914528 0.77 GAA (0.45) KDRCYP3A4MAPTMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback